Porimin Antibody (CL14381)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26852
Key Product Details
Validated by
Orthogonal Validation
Species Reactivity
Validated:
Human
Predicted:
Mouse (94%), Rat (94%). Backed by our 100% Guarantee.
Applications
Immunohistochemistry
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2B Clone # CL14381
Concentration
1 mg/ml
Product Summary for Porimin Antibody (CL14381)
Immunogen
This antibody was developed against a Synthetic Peptide of Q8N131. Actual immunogen sequence is proprietary.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Scientific Data Images for Porimin Antibody (CL14381)
Immunohistochemistry-Paraffin: Porimin Antibody (CL14381) [NBP3-26852]
Staining of human testis shows moderate to strong cytoplasmic positivity in cells in seminiferous ducts.Immunohistochemistry-Paraffin: Porimin Antibody (CL14381) [NBP3-26852]
Staining of human skeletal muscle shows no positivity in myocytes as expected.Applications for Porimin Antibody (CL14381)
Application
Recommended Usage
Immunohistochemistry
1:20 - 1:50
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Porimin
Long Name
Pro-Oncosis Receptor Inducing Membrane Injury
Alternate Names
KCT3, TMEM123
Gene Symbol
TMEM123
Additional Porimin Products
Product Documents for Porimin Antibody (CL14381)
Product Specific Notices for Porimin Antibody (CL14381)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...